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© 2011 The Japan Society of Histochemistry and Cy- We examined the fiber profiles and the mRNA levels of peroxisome proliferator-activated
receptors (PPARα and PPARδ/β) and of the PPARγ coactivator-1α (PGC-1α) in the plantaris
muscles of 15-week-old control (WR), metabolic syndrome (CP), hypertensive (SHR), and
type 2 diabetic (GK) rats. The deep regions in the muscles of SHR and GK rats exhibited
lower percentages of high-oxidative type I and IIA fibers and higher percentages of low-
oxidative type IIB fibers compared with WR and CP rats. The surface regions in the muscles
of CP, SHR, and GK rats exhibited lower percentages of high-oxidative type IIA fibers and
higher percentages of low-oxidative type IIB fibers compared with WR rats. The muscles of
SHR and GK rats had lower oxidative enzyme activity compared with WR rats. The muscles
of SHR rats had the lowest PPARδ/β mRNA level. In addition, the muscles of SHR and GK
rats had lower PGC-1α mRNA level compared with WR and CP rats. We concluded that
the plantaris muscles of rats with hypertension and type 2 diabetes have lower oxidative
capacity, which is associated with the decreased level of PGC-1α mRNA.
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I. Introduction
Mammalian skeletal muscle fibers are classified ac-
cording to differences in adenosine triphosphatase (ATPase)
activity after preincubation at different pH values [7]. Type
I (slow-twitch) and II (fast-twitch) fibers become ATPase
negative and ATPase positive at pH 10.4, respectively.
Type II fibers are subclassified as type IIA and IIB based on
ATPase stability at acidic pH; type IIA fibers lose ATPase
activity more quickly than type IIB fibers when the acidity
of the preincubation medium increases. The activity of
oxidative enzymes, e.g., succinate dehydrogenase (SDH), is
well defined in different fiber types in skeletal, perineal, and
heart muscles; oxidative enzyme activity is higher in type
I and IIA fibers compared with type IIB fibers [8, 21].
The distribution of fiber types correlates with the contraction
time and fatigue resistance of individual skeletal muscles.
Skeletal muscles that presumably contain type I and IIA
fibers are capable of relatively low-intensity activity per-
formed over a long period, such as walking and maintain-
ing posture. Conversely, skeletal muscles that presumably
contain type IIB fibers exhibit relatively high-intensity
and short-duration activity, which is required for actions
demanding strength and power.
A number of experimental animal models of metabolic
syndrome and lifestyle-related diseases, such as hyper-
tension and type 2 diabetes, have been developed. However,Nagatomo et al. 74
limited data are available on the skeletal muscle characteris-
tics of these animal models. Our previous studies [34, 35]
showed that the skeletal muscles of rats with type 2 diabetes
exhibited low oxidative capacity compared with those of
nondiabetic rats; the slow soleus and fast plantaris muscles
of the type 2 diabetic rats contained a low percentage of
high-oxidative fibers. These findings suggest that the de-
creased oxidative capacity of the skeletal muscles of type 2
diabetic rats may be associated with insulin resistance and
impaired glucose metabolism.
Oxidative metabolism in skeletal muscles is largely
regulated by several factors, such as the peroxisome
proliferator-activated receptors (PPARs) and the PPARγ
coactivator-1α (PGC-1α) [31]. Enhanced mRNA levels
of these receptors and coactivator induce an increase in
the proportion of high-oxidative fibers in skeletal muscles,
suggesting that the mRNA levels of the PPARs and PGC-1α
in skeletal muscles are associated with muscle fiber profile
parameters, such as type distribution and oxidative enzyme
activity [12, 29, 32].
Our previous study [18] showed that the slow soleus
muscles of type 2 diabetic rats exhibited a low percentage
of high-oxidative fibers and a decreased PGC-1α mRNA
level compared with those of nondiabetic rats. In the present
study, we hypothesized that similar results would be ob-
served in the fast plantaris muscles and that a reduction in
the mRNA levels of the PPARs and PGC-1α in the slow
and fast muscles may induce impaired glucose and lipid
metabolism and lead to the development and progression of
metabolic syndrome and lifestyle-related diseases.
II. Materials and Methods
All experimental and animal care procedures were
conducted in accordance with the guidelines stated in the
Guide for the Care and Use of Laboratory Animals issued
by the Institutional Animal Experiment Committee of the
Kyoto University (Kyoto, Japan).
Experimental animals and treatments
We housed 14-week-old male control Wistar (WR),
metabolic syndrome (SHR/NDmcr-cp (cp/cp), CP), sponta-
neously hypertensive (SHR), and type 2 diabetic (Goto-
Kakizaki, GK) rats (n=5 in each group) in individual,
uniformly sized standard cages for 1 week. The room was
maintained under a controlled 12 hr light/dark cycle (dark
period from 20h00 to 08h00) at 22±2°C with 45–55%
relative humidity. Food and water were provided ad libitum,
and the food intake of each rat over a 24 hr period was
measured daily.
Histochemical analyses of the muscle
At 15 weeks of age, the plantaris muscles of both
legs were removed under sodium pentobarbital anesthesia
(intraperitoneal administration, 50 mg/kg of body weight).
Excess fat and connective tissues were removed from the
muscle, and the wet weight of the muscle was measured. The
right plantaris muscle was transversely divided into two
parts (proximal and distal) for histochemical and biochemi-
cal analyses. The proximal part of the muscle was pinned
to a corkboard lengthwise, rapidly frozen in isopentane
that had been cooled with a mixture of dry ice and acetone,
and stored at −80°C until further analyses. The muscle was
mounted onto a specimen chuck using Tissue-Tek OCT
compound (Sakura Finetechnical Co. Ltd., Tokyo, Japan).
Serial transverse sections with a thickness of 10 μm were cut
on a cryostat at −20°C. The sections were brought to room
temperature, air dried for 30 min, and preincubated in acidic
solutions (pH 4.5) for the subsequent assessment of ATPase
activity (for classification of the fibers into different types)
[19, 20]. For the determination of ATPase activity, the
samples were subjected to the following treatment: (1)
preincubation for 5 min at room temperature in 50 mM
sodium acetate and 30 mM sodium barbital in distilled water
(adjusted to pH 4.5 with HCl); (2) washing in five changes
of distilled water; (3) incubation for 45 min at 37°C in 2.8
mM ATP, 50 mM CaCl2, and 75 mM NaCl in distilled
water (adjusted to pH 9.4 with NaOH); (4) washing in
five changes of distilled water; (5) immersion for 3 min in
1% CaCl2; (6) washing in five changes of distilled water; (7)
immersion for 3 min in 2% CoCl2; (8) washing in five
changes of distilled water; (9) immersion for 1 min in 1%
(NH4)2S; (10) washing in five changes of distilled water; and
(11) dehydration in graded ethanol solutions and dipping in
xylene. Fiber cross-sectional areas were measured using a
computer-assisted image processing system (Neuroimaging
System Inc., Kyoto, Japan). The cross-sectional area of the
fibers was measured by tracing the outline of each fiber in
the section. The muscle fibers in each section were classified
as type I when they exhibited a dark staining intensity, type
IIA when they exhibited a light staining intensity, and type
IIB when they exhibited an intermediate staining intensity.
Fiber type distribution and cross-sectional area were deter-
mined for approximately 200 fibers located in the deep
(close to the bone), and for approximately 200 fibers located
in the surface (away from the bone), regions of the muscle.
The sections were stained for 10 min to determine SDH
intensity. The SDH reaction was visualized by incubating
the sections in 0.1 M phosphate buffer (pH 7.6) containing
0.9 mM NaN3, 0.9 mM 1-methoxyphenazine methylsulfate,
1.5 mM nitroblue tetrazolium, 5.6 mM EDTA-disodium salt,
and 48 mM succinate disodium salt [19, 20]. The reaction
was terminated by washing in five changes of distilled
water, and the sections were dehydrated in graded ethanol
solutions and dipping in xylene. To prepare histochemical
controls, either the succinate disodium salt or the nitroblue
tetrazolium compound was excluded from the incubation
medium. The intensity of the SDH in the fibers was deter-
mined using a computer-assisted image processing system
(Neuroimaging System). The sectional images were digi-
tized as gray-scale images. Each pixel was quantified as one
of 256 of a gray level, with a gray level of 0 being equivalent
to 100% light transmission and a gray level of 255 being
equivalent to 0% light transmission. The mean opticalLifestyle-related Disease and Muscle Oxidative Capacity 75
density (OD) of all pixels within a fiber was determined
using a calibration photographic tablet with 21 steps of
gradient density ranges and the corresponding diffused-
density values.
Biochemical analyses of the muscle
The distal part of the right soleus muscle was immedi-
ately frozen and homogenized in five volumes of ice-cold
0.3 M phosphate buffer (pH 7.4) using a glass tissue homog-
enizer. The final concentrations of the compounds in the
reaction mixture were as follows: sodium succinate, 17 mM;
NaCN, 1 mM; AlCl3, 0.4 mM; and CaCl2, 0.4 mM. The
reduction of cytochrome c in this reaction mixture was ana-
lyzed using a spectrophotometer by observing the increase
in the extinction at 550 nm. SDH activity was calculated
based on ferricytochrome c concentrations and protein
content [22].
Analyses of muscle mRNA levels
Total RNA was extracted from the left soleus muscle
using the TRIzol Reagent (Invitrogen, Carlsbad, CA, USA).
The muscle was then treated with deoxyribonuclease I
(Invitrogen). The first strand of cDNA was synthesized
from 1.0 μg of total RNA using the PrimeScript RT reagent
kit (Takara Bio Inc., Shiga, Japan). We analyzed gene
expression using real-time polymerase chain reaction (RT-
PCR) on a LightCycler system DX400 (Roche Diagnostics,
Mannheim, Germany) with SYBR Premix Ex Taq II (Takara
Bio Inc.). The mRNA levels of PPARα, PPARδ/β, and
PGC-1α were normalized to those of hypoxanthine phos-











The means and standard deviations were calculated
from the individual values using standard procedures. All
measured values are presented as the mean and standard
deviation. One-way analysis of variance (ANOVA) was used
to evaluate differences among the groups. When ANOVA
analyses revealed the presence of significant differences,
further comparisons were performed using Scheffé’s post
hoc tests. A probability level of 0.05 was accepted as
significant.
III. Results
Body weight and food intake
The body weight of the CP group was the greatest
among the four groups (Fig. 1A). The body weight of the
SHR and GK groups was lower than that of the WR group.
The food intake of the CP group was the greatest
among the four groups (Fig. 1B).
Plantaris muscle weight
The muscle weight of the SHR group was the lowest
among the four groups (Fig. 1C). The muscle weight of the
CP and GK groups was lower than that of the WR group.
The relative muscle weight per body weight of the CP
and SHR groups was lower than that of the WR and GK
groups (Fig. 1D). The relative muscle weight per body
weight of the GK group was lower than that of the WR
group.
Fig. 1. Body weight (A), food intake (B),
plantaris muscle weight (C), and relative
plantaris muscle weight per body weight
(D) in the control (WR), metabolic syn-
drome (CP), hypertensive (SHR), and type
2 diabetic (GK) groups. Data are presented
as mean and standard deviation (n=5).
BW, body weight. ap<0.05 compared with
WR;  bp<0.05 compared with WR, SHR,
and GK; cp<0.05 compared with WR, CP,
and GK; dp<0.05 compared with WR and
GK.Nagatomo et al. 76
Plantaris muscle fiber profiles
All groups had three types of fibers (type I, IIA,
and IIB) in the deep regions of the muscles and two types
of fibers (type IIA and IIB) in the surface regions of the
muscles (Fig. 2).
In the deep regions of the muscles, the SHR and GK
groups had lower percentages of type I and IIA fibers and
higher percentages of type IIB fibers compared with the WR
and CP groups (Fig. 3A).
In the surface regions of the muscles, the CP, SHR, and
GK groups had lower percentages of type IIA fibers and
higher percentages of type IIB fibers compared with the WR
group (Fig. 3B).
In the deep regions of the muscles, the type I fibers
of the CP group had smaller cross-sectional areas than those
of the WR group (Fig. 3C). Furthermore, the type I fibers of
the SHR and GK groups had smaller cross-sectional areas
than those of the WR and CP groups. The type IIA fibers
of the CP, SHR, and GK groups had smaller cross-sectional
areas than those of the WR group. The type IIB fibers of
the CP and GK groups had smaller cross-sectional areas
than those of the WR group. Furthermore, the type IIB
fibers of the SHR group had the smallest cross-sectional area
recorded among the four groups.
In the surface regions of the muscles, the type IIA
fibers of the CP, SHR, and GK groups had smaller cross-
sectional areas than those of the WR group (Fig. 3D). The
type IIB fibers of the CP and GK groups had smaller cross-
sectional areas than those of the WR group. Furthermore, the
type IIB fibers of the SHR group had smaller cross-sectional
areas than those of the WR and CP groups.
In the deep and surface regions of the muscles, the type
IIA and IIB fibers of the SHR and GK groups had lower
SDH intensities than those of the WR and CP groups
(Fig. 3E, F).
Plantaris muscle SDH activity
The muscles of the SHR and GK groups had lower
SDH activities than those of the WR group (Fig. 4).
mRNA levels in the plantaris muscle
There were no differences in PPARα mRNA level of
the muscles from the four groups (Fig. 5A). The PPARδ/β
mRNA level in the muscles of the SHR group was the lowest
Fig. 2. Photomicrographs of serial transverse sections of the plantaris muscles stained for adenosine triphosphatase activity after preincubation
at pH 4.5 (A, C, E, G, I, K, M, and O) and for succinate dehydrogenase activity (B, D, F, H, J, L, N, and P) in control (WR, A–D), metabolic
syndrome (CP, E–H), hypertensive (SHR, I–L), and type 2 diabetic (GK, M–P) rats. The photomicrographs in the two left-side columns are
from deep regions of the muscles and the photomicrographs in the two right-side columns are from the surface regions of the muscles. 1, type I;
2, type IIA; 3, type IIB. Scale bar in P, 50 μm for all photomicrographs.Lifestyle-related Disease and Muscle Oxidative Capacity 77
among the four groups (Fig. 5B). The PGC-1α mRNA level
in the muscles of the SHR and GK groups was lower than
that of the WR and CP groups (Fig. 5C).
IV. Discussion
Skeletal muscles of patients with type 2 diabetes have
a decreased oxidative capacity compared with those of
healthy individuals, as the skeletal muscles of the former
contain a low percentage of high-oxidative fibers [3, 6, 14,
23]. These findings suggest that the decreased oxidative
capacity of skeletal muscles in patients with type 2 diabetes
is associated with insulin resistance and impaired glucose
metabolism.
Mammalian skeletal muscles are classified into two
types, slow and fast muscles, based on their metabolic and
functional properties. The normal activity patterns differ
between slow and fast muscles; slow muscles exhibit an
activity of relatively low-intensity and long-duration, which
is required for performing functions against gravity, such
as walking and posture maintenance, whereas fast muscles
exhibit an activity of relatively high-intensity and short-
duration, which is required for functions demanding strength
and power. Unlike slow muscles, which presumably contain
high-oxidative fibers, fast muscles presumably contain low-
Fig. 3. Fiber type distribution (A and B), cross-sectional area (C and D), and succinate dehydrogenase intensity (E and F) in the deep (A, C, and
E) and surface (B, D, and F) regions of the plantaris muscles of the control (WR), metabolic syndrome (CP), hypertensive (SHR), and type 2
diabetic (GK) groups. Data are presented as mean and standard deviation (n=5). CSA, cross-sectional area; SDH, succinate dehydrogenase; OD,
optical density. ap<0.05 compared with WR; cp<0.05 compared with WR, CP, and GK; ep<0.05 compared with WR and CP.
Fig. 4. Succinate dehydrogenase activity in the plantaris muscles of
the control (WR), metabolic syndrome (CP), hypertensive (SHR),
and type 2 diabetic (GK) groups. Data are presented as mean and
standard deviation (n=5). SDH, succinate dehydrogenase. ap<0.05
compared with WR.Nagatomo et al. 78
oxidative fibers that exhibit decreased lipid storage capacity
[2], insulin binding [1, 11], insulin-stimulated glucose up-
take [9], and glucose-transport protein content [4, 15]. It
is unclear whether these differences between the slow and
fast muscles of rats with metabolic syndrome and lifestyle-
related diseases affect fiber profiles and the mRNA levels.
In the present study, we focused on the mRNA levels
of PPARs and PGC-1α in the skeletal muscles, as PPARα
and PPARδ/β directly regulate the expression of certain
nuclear-encoded mitochondrial genes and are closely related
to the regulation of oxidative metabolism via PGC-1α [10,
26]. PGC-1α has emerged as a major regulator of multiple
cellular processes, including oxidative metabolism and fiber
type specialization in skeletal muscles, and is considered to
be predominantly involved in the regulation of mitochon-
drial content and function, which are closely related to SDH
activity in the tricarboxylic acid cycle [12, 13, 16, 25, 33].
Our previous study [18] showed that the slow soleus
muscles of type 2 diabetic GK rats had lower PGC-1α
mRNA level than those of control WR rats. In addition, the
soleus muscles of WR rats had type I, IIA, and IIC fibers,
whereas those of GK rats had only type I fibers, which ex-
hibit a lower oxidative enzyme activity compared with type
IIA and IIC fibers [8, 27, 28]. Therefore, we concluded that
the lower PGC-1α mRNA level observed in the slow soleus
muscles of rats with type 2 diabetes was associated with the
exclusive presence of low-oxidative fibers. In the present
study, we investigated the fiber profiles and the mRNA
levels of PPARα, PPARδ/β, and PGC-1α in the fast
plantaris muscles of metabolic syndrome, hypertensive, and
type 2 diabetic rats to examine whether the fast plantaris
muscles yield results that are similar to those observed for
the slow soleus muscles.
mRNA levels of PPARs in the fast plantaris muscle
PPARα is expressed at high levels in the liver, kidney,
skeletal muscle, adipose tissue, and vascular wall, which
are tissues that are important for insulin sensitivity and
resistance, glucose metabolism, and the regulation of blood
pressure. PPARδ/β is the main transcription factor involved
in fatty-acid oxidation in skeletal muscles and is activated by
enzymes associated with long-chain fatty-acid β-oxidation
[24].
In our previous study [18], the PPARδ/β mRNA level
in the slow soleus muscles of CP, SHR, and GK rats was
lower than that observed in control WR rats. This result
suggests that experimental animal models of metabolic syn-
drome and lifestyle-related diseases exhibit low PPARδ/β
mRNA level in skeletal muscles, irrespective of the type of
disease. In the present study, the PPARδ/β mRNA level in
the fast plantaris muscles of SHR rats, but not of CP and GK
rats, was lower than that observed in the muscles of WR
rats. These results suggest that the plantaris muscles of SHR
rats have a decreased capacity for fatty-acid oxidation. This
finding is consistent with the result of our previous study
using the soleus muscles of SHR rats [18]. However, in the
present study, the PPARδ/β mRNA level in the plantaris
muscles of CP and GK rats did not differ from that observed
in the muscles of WR rats. We did not elucidate why there
were no differences in PPARδ/β mRNA level in the planta-
ris muscles of CP and GK rats and SHR rats; however, we
speculate that there are muscle-type specific differences in
PPARδ/β mRNA level in rats with metabolic syndrome and
lifestyle-related diseases.
mRNA level of PGC-1α in the fast plantaris muscle
PGC-1α, which was originally identified as a nuclear
receptor coactivator, is expressed in several tissues, includ-
ing brown adipose tissue, skeletal muscle, heart, kidney,
liver, and brain, and activates mitochondrial biogenesis and
function [12, 17]. PGC-1α is also believed to be a key
molecule involved in fatty-acid oxidation, as it interacts
with PPARα to promote the transcription of nuclear genes
that encode mitochondrial fatty-acid-oxidation enzymes
[30].
The oxidative metabolism in skeletal muscles is largely
regulated by PGC-1α, which coactivates PPARγ [31].
Therefore, a decrease in PGC-1α expression is associated
with a reduced oxidative metabolism, which may induce in-
sulin resistance and impaired glucose metabolism, whereas
Fig. 5. PPARα (A), PPARδ/β (B), and PGC-1α (C) mRNA levels in the plantaris muscles of the control (WR), metabolic syndrome (CP),
hypertensive (SHR), and type 2 diabetic (GK) groups. Data are presented as mean and standard deviation (n=5). The mRNA levels of each gene
were normalized to those of hypoxanthine phosphoribosyltransferase (HPRT). PPAR, peroxisome proliferator-activated receptor; PGC, PPARγ
coactivator. cp<0.05 compared with WR, CP, and GK; ep<0.05 compared with WR and CP.Lifestyle-related Disease and Muscle Oxidative Capacity 79
an increase in PGC-1α expression can result in an improve-
ment of insulin resistance and impaired glucose metabolism.
An increase in PGC-1α mRNA level induces an increase
in the proportion of high-oxidative fibers in the skeletal
muscles of transgenic mice [12]; this suggests that PGC-1α
regulates the proportion of high-oxidative fibers in skeletal
muscles. These findings were confirmed in skeletal muscles
of diabetic rats; exposure to hyperbaric oxygen induced an
enhancement of the PGC-1α mRNA level, a shift of fiber
type from low- to high-oxidative, and an increase in fiber
oxidative enzyme activity in the soleus and plantaris mus-
cles of rats with type 2 diabetes [5, 36]. In the present study,
a decrease in PGC-1α mRNA level was observed in the
plantaris muscles of SHR and GK rats (Fig. 5C), and the
oxidative capacity of the plantaris muscles of these rats was
reduced (Figs. 3E, F and 4).
It is interesting to note that fiber type distribution
(Fig. 3A, B; with the one exception that type IIA fiber
percentages were lower and type IIB fiber percentages
were higher in the surface regions of the muscles in CP
rats), fiber SDH intensity (Fig. 3E, F), and muscle SDH
activity (Fig. 4) in the plantaris muscles of CP rats were
similar to those observed for WR rats. Furthermore, there
were no differences in PPARα, PPARδ/β, or PGC-1α
mRNA level in the plantaris muscles of CP and WR rats
(Fig. 5). Our previous study [18] showed that 15-week-old
CP rats had greater body weight and food intake compared
with age-matched WR, SHR, and GK rats. Furthermore, CP
rats had the highest levels of triglycerides, total cholesterol,
LDL cholesterol, free fatty acids, and insulin. Blood glucose
levels and systolic blood pressure were lower in CP rats
than they were in GK and SHR rats, respectively, although
these parameters were higher in CP rats compared with WR
rats; therefore, 15-week-old CP rats were prediabetic and
prehypertensive. We concluded that rats with metabolic
syndrome under prediabetic and prehypertensive conditions
have normal fiber profiles and mRNA levels of PPARs and
PGC-1α in skeletal muscles.
Our previous study [18] demonstrated that the slow
soleus muscles of rats with type 2 diabetes exhibited a
decrease in PGC-1α mRNA level compared with control
WR rats. In addition, the soleus muscles of GK rats had
low-oxidative fibers exclusively. In the present study, the
fast plantaris muscles of rats with hypertension and type
2 diabetes had an increased percentage of low-oxidative
fibers, which was associated with a decrease in PGC-1α
mRNA level. Therefore, we concluded that rats with hyper-
tension and type 2 diabetes had decreased PGC-1α mRNA
level, irrespective of muscle type. It is suggested that the
decreased oxidative capacity of the skeletal muscles, which
may be associated with insulin resistance and impaired glu-
cose metabolism, is because of decreased PGC-1α mRNA
level in rats with hypertension and type 2 diabetes.
Fiber cross-sectional area in the fast plantaris muscle
The muscle weight of CP, SHR, and GK rats was lower
than that of WR rats (Fig. 1C). This result correlated well
with the finding of smaller cross-sectional areas in all types
of fibers in the muscles of CP, SHR, and GK rats compared
with corresponding types of fibers in WR rats (Fig. 3C,
D). It is suggested that the decreased muscle weight and
fiber cross-sectional area observed in SHR and GK rats are
because of their lower body weight compared with those
of WR rats (Fig. 1A). In contrast, the body weight of CP
rats was the highest among the four groups (Fig. 1A). We
believe that the increased body weight of CP rats was
because of obesity, which is associated with various meta-
bolic disorders and cardiovascular diseases, and that obesity
in CP rats did not affect plantaris muscle weight and fiber
cross-sectional area. The findings obtained for the fast
plantaris muscles differed from the results of our previous
studies, which showed that the slow soleus muscles of CP
rats were smaller compared with those observed for WR,
SHR, and GK rats because of atrophy of all types of fibers in
the soleus muscles of CP rats [18]. We suggest that the slow
soleus muscles of CP rats induce a more severe atrophy
because this type of muscle is an antigravity and posture
muscle that is persistently active; therefore, the size of its
fibers is more dependent on muscle activity and loading
levels.
Conclusion
The present study showed that the deep regions of
the plantaris muscles of SHR and GK rats had lower per-
centages of high-oxidative type I and IIA fibers and higher
percentages of low-oxidative type IIB fibers than those of
WR rats. The plantaris muscles of SHR and GK rats had
lower oxidative enzyme activity compared with those of
WR rats. Furthermore, the plantaris muscles of SHR and GK
rats had lower PGC-1α mRNA levels than those of WR
rats. We concluded that the plantaris muscles of rats with
hypertension and type 2 diabetes have lower oxidative
capacity, which is associated with the decreased level of
PGC-1α mRNA.
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